Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$79.33 USD
+0.02 (0.03%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $79.32 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Edwards Lifesciences Corporation has a market cap of $46.52B, which represents its share price of $79.31 multiplied by its outstanding shares number of 586.60M. As a large-cap company, EW's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EW 79.33 +0.02(0.03%)
Will EW be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EW based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EW
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
EW: What are Zacks experts saying now?
Zacks Private Portfolio Services
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings
Other News for EW
Citadel Advisors LLC Increases Stake in NioCorp Developments Ltd
Agree To Purchase Edwards Lifesciences At $65, Earn 5.2% Using Options
Edwards Lifesciences Corp (EW)'s Winning Formula: Financial Metrics and Competitive Strengths
Sarepta upgraded, Tapestry downgraded: Wall Street's top analyst calls
Daiwa gets more bullish on Edwards Lifesciences, upgrades shares